Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Malignant hyperthermia. 1962.

Denborough MA.

Anesthesiology. 2008 Jan;108(1):156-7. No abstract available.

PMID:
18156894
2.

Dantrolene and "ecstasy".

Denborough MA, Hopkinson KC.

Med J Aust. 1997 Feb 3;166(3):165-6. No abstract available.

PMID:
9059444
3.

Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia.

O'Brien RO, Taske NL, Hansbro PM, Matthaei KI, Hogan SP, Denborough MA, Foster PS.

J Med Genet. 1995 Nov;32(11):913-4.

4.

Molecular cloning of the cDNA encoding human skeletal muscle triadin and its localisation to chromosome 6q22-6q23.

Taske NL, Eyre HJ, O'Brien RO, Sutherland GR, Denborough MA, Foster PS.

Eur J Biochem. 1995 Oct 1;233(1):258-65.

5.

The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle.

Foster PS, Hogan SP, Hansbro PM, O'Brien R, Potter BV, Ozaki S, Denborough MA.

Eur J Biochem. 1994 Jun 15;222(3):955-64.

6.

Purification and characterization of D-myo-inositol (1,4,5)/(1,3,4,5)- polyphosphate 5-phosphatase from skeletal muscle.

Hansbro PM, Foster PS, Hogan SP, Ozaki S, Denborough MA.

Arch Biochem Biophys. 1994 May 15;311(1):47-54.

PMID:
8185320
7.

Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism.

Hansbro PM, Foster PS, Liu C, Potter BV, Denborough MA.

Biochem Biophys Res Commun. 1994 Apr 15;200(1):8-15.

PMID:
8166746
8.

A clinical grading scale to predict malignant hyperthermia susceptibility.

Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, Kaplan RF, Muldoon SM, Nelson TE, Ording H, et al.

Anesthesiology. 1994 Apr;80(4):771-9.

PMID:
8024130
9.

Detection and partial purification of inositol 1,4,5-trisphosphate 3-kinase from porcine skeletal muscle.

Hogan SP, Foster PS, Hansbro PM, Ozaki S, Denborough MA.

Cell Signal. 1994 Feb;6(2):233-43.

PMID:
8086287
10.

Fatal inherited rhabdomyolysis and malignant hyperthermia.

Denborough MA, McLean A, Morgan G, Hopkinson KC.

Lancet. 1994 Jan 22;343(8891):236-7. No abstract available.

PMID:
7904690
11.

Inositol 1,4,5-trisphosphate metabolism in red blood cells from individuals susceptible to malignant hyperpyrexia.

Foster PS, Gesini E, Denborough MA.

Lancet. 1993 Oct 16;342(8877):986-7. No abstract available.

PMID:
8105231
12.
13.

Propofol anaesthesia in malignant hyperpyrexia susceptible swine.

Foster PS, Hopkinson KC, Denborough MA.

Clin Exp Pharmacol Physiol. 1992 Mar;19(3):183-6.

PMID:
1521353
14.
15.

Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle.

Foster PS, Hopkinson KC, Denborough MA.

Clin Exp Pharmacol Physiol. 1989 Oct;16(10):799-805.

PMID:
2612062
16.

Inositol 1,4,5-trisphosphate phosphatase deficiency and malignant hyperpyrexia in swine.

Foster PS, Gesini E, Claudianos C, Hopkinson KC, Denborough MA.

Lancet. 1989 Jul 15;2(8655):124-7.

PMID:
2567894
18.

Effect of diltiazem on porcine malignant hyperpyrexia induced by suxamethonium and halothane.

Foster PS, Hopkinson KC, Denborough MA.

Br J Anaesth. 1989 May;62(5):560-5.

19.

31P-NMR spectroscopy: the metabolic profile of malignant hyperpyrexic porcine skeletal muscle.

Foster PS, Hopkinson K, Denborough MA.

Muscle Nerve. 1989 May;12(5):390-6.

PMID:
2725566
20.

Calcium currents and asymmetric charge movement in malignant hyperpyrexia.

Lamb GD, Hopkinson KC, Denborough MA.

Muscle Nerve. 1989 Feb;12(2):135-40.

PMID:
2540432
22.

Calmodulin-antagonist drugs and porcine malignant hyperpyrexia.

Collins SP, White MD, Denborough MA.

Clin Exp Pharmacol Physiol. 1988 Jun;15(6):473-7.

PMID:
3271620
23.

Firefighting and malignant hyperthermia.

Denborough MA, Hopkinson KC, Banney DG.

Br Med J (Clin Res Ed). 1988 May 21;296(6634):1442-3. No abstract available.

24.

Effects of adenylate cyclase activators on porcine skeletal muscle in malignant hyperpyrexia.

Sim AT, White MD, Denborough MA.

Br J Anaesth. 1987 Dec;59(12):1557-62.

25.

The effect of oxytocin on porcine malignant hyperpyrexia susceptible skeletal muscle.

Sim AT, White MD, Denborough MA.

Clin Exp Pharmacol Physiol. 1987 Jul;14(7):605-10.

PMID:
3436105
26.

Thiophosphorylation of skeletal muscle sarcoplasmic reticulum in porcine malignant hyperpyrexia.

Sim AT, White MD, Denborough MA.

Int J Biochem. 1987;19(12):1217-24.

PMID:
3436481
27.

Calmodulin in porcine malignant hyperpyrexia.

Collins SP, White MD, Denborough MA.

Int J Biochem. 1987;19(1):63-70.

PMID:
3032704
28.
29.
30.

Suxamethonium chloride and malignant hyperpyrexia.

Galloway GJ, Denborough MA.

Br J Anaesth. 1986 Apr;58(4):447-50.

31.

Calmodulin and malignant hyperpyrexia.

Marjanen LA, Collins SP, Denborough MA.

Biochem Med. 1984 Oct;32(2):283-7.

PMID:
6095821
32.

Rhabdomyolysis and malignant hyperpyrexia.

Denborough MA, Collins SP, Hopkinson KC.

Br Med J (Clin Res Ed). 1984 Jun 23;288(6434):1878. No abstract available.

33.

Phosphorus-31 nuclear magnetic resonance studies of muscle metabolism in malignant hyperpyrexia.

Galloway GJ, Denborough MA.

Br J Anaesth. 1984 Jun;56(6):663-4. No abstract available.

34.

Electrophoretic analysis of proteins in malignant hyperpyrexia susceptible skeletal muscle.

Marjanen LA, Denborough MA.

Int J Biochem. 1984;16(8):919-29.

PMID:
6468747
35.
36.
37.
38.

A novel method for the isolation of calsequestrin from porcine skeletal muscle sarcoplasmic reticulum.

White MD, Thomas CR, Denborough MA.

Biochim Biophys Acta. 1983 Apr 14;744(1):1-6.

PMID:
6219708
39.

Comparison of adenylate kinase from normal and malignant hyperpyrexic porcine muscle.

Marjanen LA, Shaw DC, Denborough MA.

Biochem Med. 1983 Apr;29(2):164-70.

PMID:
6305346
40.

Malignant hyperpyrexia and sudden infant death.

Denborough MA, Galloway GJ, Hopkinson KC.

Lancet. 1982 Nov 13;2(8307):1068-9. No abstract available.

PMID:
6127545
41.

Clodanolene sodium and malignant hyperpyrexia.

Sullivan JS, Galloway GJ, Denborough MA.

Br J Anaesth. 1982 Nov;54(11):1237. No abstract available.

42.

Adenylate kinase and malignant hyperpyrexia.

Marjanen LA, Denborough MA.

Br J Anaesth. 1982 Sep;54(9):949-52. No abstract available.

43.

Platelet function in malignant hyperpyrexia.

Sullivan JS, Ardlie NG, Denborough MA.

Br J Anaesth. 1982 Aug;54(8):900-1. No abstract available.

PMID:
7104140
44.

Effect of halothane on adenylate kinase in porcine malignant hyperpyrexia.

Marjanen LA, Denborough MA.

Clin Chim Acta. 1982 Jul 1;122(2):225-30.

PMID:
6286170
45.

Heat stroke and malignant hyperpyrexia.

Denborough MA.

Med J Aust. 1982 Mar 6;1(5):204-5. No abstract available.

PMID:
7087832
46.

The effects of imidazole on contractility and cyclic AMP levels of guinea-pig tracheal smooth muscle.

Creese BR, Denborough MA.

Clin Exp Pharmacol Physiol. 1982 Mar-Apr;9(2):145-55.

PMID:
6290117
47.
48.

Temperature dependence of muscle function in malignant hyperpyrexia-susceptible swine.

Sullivan JS, Denborough MA.

Br J Anaesth. 1981 Nov;53(11):1217-22.

49.

Sudden infant death syndrome and malignant hyperpyrexia.

Denborough MA.

Med J Aust. 1981 Jun 13;1(12):649-50. No abstract available.

PMID:
7254063
50.

Sources of calcium for contraction of guinea-pig isolated tracheal smooth muscle.

Creese BR, Denborough MA.

Clin Exp Pharmacol Physiol. 1981 Mar-Apr;8(2):175-82.

PMID:
6788415

Supplemental Content

Loading ...
Support Center